Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) surged +2.59% and closed the trade at $ 1.19. The company recorded a trading capacity of 1.25 million shares below its three months average daily volume of 3.44 million shares. During the last trade, shares reached to high price of $1.19 and touched the low price of $1.13. The stock’s 50-day moving average is noted at $0.83 and its 200-day moving average is stands at $0.55.
Additionally, the company has a PE ratio of 2.01 and has EPS of 0.59. The company has market capitalization of $85.10M.
Currently Threshold Pharmaceuticals, Inc. (THLD) captured an average recommendation of “ Overweight ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “1″ Analyst”. “0” rated “Sell” for the company. “1” said the company as a “Hold”. Overweight rating was given by “0” and Underweight rating was given by “0”.
Presently, Analysts decided consensus EPS estimate of $-0.08 for present quarter and one month ago projected EPS estimate was at $-0.08. If we take a look at back 3 month ago, consensus EPS estimate was $-0.11.
A current consensus EPS estimate for next quarter is at $-0.08 and 3 month ago EPS forecast was $-0.11. Have a look at back 1 month ago, consensus EPS forecast was seen at $-0.08.
For current fiscal year, most recent EPS estimate is set at $-0.37 based on Analyst consensus and three month ago consensus EPS opinions was at $-0.46. During period one month ago, consensus EPS forecast was decided at $-0.37.
A current consensus EPS projection for next fiscal year is observed at $-0.30 and one month ago consensus EPS forecast was at $-0.30. Take a look at back three month ago, consensus EPS estimate opinions was decided at $-0.41 by analysts.
One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. 1 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 0. 1 advised the “Hold” rating about this stock. 0 revealed “Sell” signal and “Underweight” rating was declared by 0.
Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 1 said a “Buy Rating” and 0 announced “Overweight Rating”. 1 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.